Captura

Institut Català de la Salut, Spain  

COVID-19 immunity in healthcare professionals

Determining whether there is protection against reinfection is important for controlling healthcare workers implications during the pandemic due to their continous professional contact with COVID-19 patients

Catalunya Central Health region, Spain  

COnV-ert study, convalescent plasma to stop COVID-19

Early administration of convalescent plasma in people over 50 years of age with mild to moderate COVID-19 disease may slow disease progression and decrease the severity of symptoms.

Technische Universität München, Germany  

CoViproteHCt

Identifying true markers of protective immunity will allow for the identification of individuals, in particular healthcare personnel working with COVID-19 patients and in other critical areas protected from re-infection.

Catalonia, Spain  

COVICAT Study

The COVICAT study aims to evaluate the evolution of the incidence of SARS-CoV-2 coronavirus infection in the Catalan population over a 12-month period.

Assistance Publique des Hopitaux de Paris, France  

Convalescent plasma therapy and COVID-19

Convalescent plasma with anti-SARS-CoV-2 antibodies appears to be a very promising approach in the context of protracted COVID-19 symptoms in patients unable to mount a specific humoral response to SARS-CoV-2.

Covonco

SAAS, Andorra  

COVonco Study

Join the COVonco study and help understand the impact of COVID-19 in oncology.

Fbdaf53c E60c 4f8c 9af5 Ce08e8ca65f0 4 5005 C

France  

EpiCOV

The EpiCOV project aims to provide a global and scientifically reliable mapping of the immune status of the population in France through serological tests and questionnaires.

Imperial College London et al., United Kingdom  

REACT-2.5: Seroprevalence of SARS-CoV-2 antibodies

This cross-sectional study estimates SARS-CoV-2 IgG antibody seroprevalence in the community in England using self-administered LFIAs.

Covid 5905183 1920

Imperial College London et al., United Kingdom  

REACT-2.4: Usability of LFIA Self-testing in Key Workers

Study that assesses whether LFIAs should be used as a self-administered test among key workers or whether better performance is obtained if they attend a central clinic facility.

Imperial College London et al., United Kingdom  

REACT-2.3: Acceptability and Usability of In-home Self-testing for SARS-CoV-2

This COVID-19 study aims to evaluate the acceptability and usability of in-home self-testing for SARS-CoV-2 antibodies.

Home Test 2

Imperial College London et al., United Kingdom  

REACT-2.2: Feasibility of COVID-19 Self-testing

Which are the issues of self-testing? This study aims to assess the feasibility of finger-prick antibody testing at home to prove the design of the larger-scale COVID-19 studies.

Test Antigens Mascareta 2

Imperial College London et al., United Kingdom  

REACT-2.1: Evaluation of SARS-CoV-2 lateral flow immunoassays

How accurate are lateral flow immunoassays? This epidemiological study compares LFIAs with other COVID-19 tests.